Why are investors concerned about Marvell's custom AI chips business?

Marvell Technology's stock declined despite better-than-expected Q1 results and guidance, as investors are concerned about the company's dependence on Amazon's custom AI chip (Trainium) business; specifically, doubts about future chip development and competition from AIchip are weighing on investor sentiment. Analysts at Morgan Stanley and Melius Research have expressed concerns about the concentration of Marvell's ASIC business and potential revenue erosion, leading Jim Cramer to suggest Broadcom as a more attractive alternative for exposure to custom AI chips, though Piper Sandler maintains an "overweight" rating with a $95 price target.

Analysis

Marvell Technology (MRVL) experienced a notable stock decline, falling as much as 7.0%, despite reporting fiscal Q1 results marginally above Street estimates and guiding for continued strong AI-driven growth in its data-center segment. This adverse reaction stems primarily from investor concerns regarding the concentration of its custom AI chip business with a single major client, Amazon, for its Trainium chips. Specifically, uncertainties surrounding the timely launch and execution of Amazon's next-generation Trainium chips, as highlighted by Morgan Stanley analysts, undermine confidence in the long-term stability and visibility of Marvell's ASIC revenue, with concerns that its prospects rely heavily on this single chip's success. Further amplifying these concerns, Melius Research has pointed to the potential competitive threat from Taiwan-based AIchip for future Amazon chip designs (Trainium 3 and Trainium 4), which could lead to revenue erosion or limited upside for Marvell. This customer dependency, with famed investor Jim Cramer noting the need for more hyperscaler clients, overshadows the positive quarterly performance and guidance, especially considering the stock had already been cut in half since late January. While Piper Sandler maintains a bullish "overweight" rating and raised its price target to $95, citing expectations for AI to drive revenue and a material acceleration in XPU volume, the prevailing market sentiment, reflected in the stock's drop, indicates significant apprehension about Marvell's narrow AI customer base and project execution risks.

Key Decisions for Investors

• Investors should critically assess Marvell's significant customer concentration risk with Amazon and monitor for any updates regarding the execution of future Trainium chip projects and potential competition from AIchip.
• Consider the divergent analyst opinions, weighing the highlighted execution risks and the need for client diversification against Piper Sandler's optimistic outlook driven by expected XPU volume acceleration.
• Evaluate alternative investments for custom AI chip exposure, such as Broadcom (AVGO), which market commentators suggest may offer a more diversified risk profile in the segment.
• Closely watch for Marvell's ability to secure additional hyperscaler clients, as this would be a key catalyst to mitigate current dependency concerns and validate its long-term AI growth narrative.